Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

Auteurs : Burstein HJ, Piccart-Gebhart M, Perez EA, Hortobagyi GN, Wolmark N, Albain KS, Norton L, Winer EP, Hudis CA
Jaar : 2012
Journal : J. Clin. Oncol.
Volume : 30(18)
Pagina's : 2179-82